SCHEMBL6862675

SCHEMBL6862675

CSc1ccc2c(c1)C(NN)=NCc1c(C3=CN(C4CC4)NO3)ncn1-2

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7708380 0.77 GABRG2 (0.38)
SCHEMBL6866950 0.63 GABRG2 (0.39)
SCHEMBL6871034 0.57 GABRA1 (0.34)
SCHEMBL6866654 0.55 GABRG2 (0.45)
SCHEMBL23638516 0.49 FGFR1 (0.47)
SCHEMBL11829518 0.49 CHRM1 (0.30)
SCHEMBL11845687 0.48 CHRM1 (0.49)
SCHEMBL11829806 0.47 CHRM1 (0.30)
SCHEMBL20884950 0.45 ALDH1A1 (0.41)
SCHEMBL28058700 0.44 DRD2 (0.47)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1337535-B1 BENZODIAZEPINE DERIVATIVES AS GABA A RECEPTOR MODULATORS HOFFMANN LA ROCHE (CH) 2004-06-09 EP disclosed
US-6743789-B2 SUBSTITUTED IMIDAZO (1,5-A) (1,2,4) TRIAZOLO (4,3-D) (1,4) BENZODIAZEPINE DERIVATIVES ARE USEFUL FOR TREATING ALZHEIMER'S DISEASE; REACTING A BEZODIAZEPINE DERIVATIVE WITH A HYDRAZIDE DERIVATIVE TO FORM END PRODUCT HOFFMANN-LA ROCHE INC. 2004-06-01 US disclosed
US-20020103371-A1 Substituted imidazo [1,5-a] [1,2,4] triazolo [4,3-d] [1,4] benzodiazepine derivatives HOFFMANN-LA ROCHE INC. 2002-08-01 US disclosed